Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy.

Chih-Lang LinSzu-Yuan WuMing-Wei LaiChao-Wei HsuWan-Ming ChenAn-Tzu JaoCheng-Hung ChienChing-Chih HuRong-Nan ChienChau-Ting Yeh

Published in: Cancers (2023)

Our predictive scoring system is a promising tool for the prediction of HCC in CHB patients receiving finite NA treatments. Genotype C, NA-withdraw-related hepatitis relapse, male gender, liver cirrhosis, and the T1768A HBV core promoter mutation were significant independent risk factors.

Keyphrases

hepatitis b virus
risk factors
dna methylation
gene expression
transcription factor
liver failure
mental health
free survival
stem cells
bone marrow
drug induced